Compare BioNano Genomics Inc (BNGO) vs Comfort Systems USA Inc (FIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Comfort Systems USA Inc — how do they compare? BioNano Genomics Inc trades at $1.17 (market cap $13.66M), while Comfort Systems USA Inc trades at $1,745 (market cap $59.41B). The key difference: Comfort Systems USA Inc is far larger — about 4349.2× BioNano Genomics Inc's market cap, and Comfort Systems USA Inc pays a 0.21% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | FIX | |
|---|---|---|
Market Cap | $13.66M | $59.41B |
Sector | Health | Technology |
52-Week High | $4.92 | $2.07K |
52-Week Low | $1.06 | $680.86 |
Enterprise Value | $16.26M | $57.88B |
Dividend Yield | — | 0.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.16 with a bullish technical signal supported by moving averages. The company shows improving financial trends with narrowing losses and consistent earnings beats, though it remains unprofitable with negative margins. Recent news highlights operational progress including debt retirement and scientific publications. Valuation ratios appear attractive with P/S of 0.31 and P/B of 0.36.
The outlook remains speculative given persistent losses, but improving cash flow trends and analyst optimism provide catalysts. Key risks include ongoing negative profitability and competitive pressures in genomics. With 57% analyst buy ratings and bullish technical momentum, the stock offers high-risk growth potential for investors comfortable with biotech volatility.
Comfort Systems USA (FIX) trades at $1,750.90, up 4.54% with strong earnings momentum as Q2 2026 EPS of $12.53 beat expectations by 20%. The stock shows bearish technical signals but maintains robust fundamentals with 55.29% ROE and record backlog driven by data center demand. Recent news highlights margin expansion and institutional position adjustments.
Outlook remains positive given analyst consensus price target of $2,170 (24% upside), though premium valuation (P/E 41.55) and execution risks warrant caution. Key opportunities include AI-driven data center growth, while risks involve capacity constraints and market volatility near technical resistance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Comfort Systems USA Inc
Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.
Read more on FIX →
